These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38984096)

  • 21. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
    Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH
    Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning.
    Badros A; Tricot G; Toor A; Morris C; Guo C; Munshi N; Barlogie B; Cottler-Fox M
    Transfusion; 2002 Feb; 42(2):205-9. PubMed ID: 11896336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of red blood cell destruction by graft-derived antibodies after minor ABO-mismatched heart and lung transplantation.
    Hunt BJ; Yacoub M; Amin S; Devenish A; Contreras M
    Transplantation; 1988 Aug; 46(2):246-9. PubMed ID: 3136561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of ABO blood group incompatibility on the outcomes of allogeneic hematopoietic stem cell transplantation.
    Ciftciler R; Goker H; Buyukasık Y; Karaagac T; Aksu S; Tekin F; Demiroglu H
    Transfus Apher Sci; 2020 Feb; 59(1):102597. PubMed ID: 31311753
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is ABO mismatch another risk factor for allogeneic hematopoietic stem cell transplantation in pediatric thalassemic patients?
    Atay D; Erbey F; Akcay A; Ozturk G
    Pediatr Transplant; 2015 Sep; 19(6):645-51. PubMed ID: 26156679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. UGT1A1 mutation association with increased bilirubin levels and severity of unconjugated hyperbilirubinemia in ABO incompatible newborns of China.
    Yang H; Lin F; Chen ZK; Zhang L; Xu JX; Wu YH; Gu JY; Ma YB; Li JD; Yang LY
    BMC Pediatr; 2021 Jun; 21(1):259. PubMed ID: 34074250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [ABO incompatibility and non myeloablative allogeneic stem cell transplantation].
    Malfuson JV; Hicheri Y; Bonin P; Rodet M; Boccaccio C; Pautas C; Kuentz M; Cordonnier C; Noizat-Pirenne F; Maury S
    Transfus Clin Biol; 2007 Aug; 14(3):327-33. PubMed ID: 17462938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Consequences of ABO incompatibility in multiple myeloma patients undergoing peripheral blood stem cell transplantation after reduced intensity conditioning.
    Marenchino D; Maddalena L; Balbo R; Avonto I; Menardi G; Prucca M; Perotti L; Mordini N; Peano G
    Blood Transfus; 2011 Jan; 9(1):79-85. PubMed ID: 21084015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Ataca Atilla P; Akkus E; Atilla E; Gokmen N; Civriz Bozdag S; Kocak Toprak S; Kurt Yuksel M; Ozcan M; Demirer T; Ilhan O; Beksac M; Akan H; Arslan O; Topcuoglu P; Gurman G
    Transfus Clin Biol; 2020 Aug; 27(3):115-121. PubMed ID: 32659269
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of ABO-incompatible donor on early and late outcome of hematopoietic stem cell transplantation.
    Ozkurt ZN; Yegin ZA; Yenicesu I; Aki SZ; Yagci M; Sucak GT
    Transplant Proc; 2009 Nov; 41(9):3851-8. PubMed ID: 19917400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of neonatal hyperbilirubinemia in babies born to 'O' positive mothers: a prospective cohort study.
    Kalakheti BK; Singh R; Bhatta NK; Karki A; Baral N
    Kathmandu Univ Med J (KUMJ); 2009; 7(25):11-5. PubMed ID: 19483446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histological features of renal allograft biopsies in ABO minor-mismatched kidney transplantation.
    Shimizu T; Tanabe K; Tokumoto T; Shimmura H; Ishikawa N; Ishida H; Toma H; Kawaguchi H; Tokiwa M; Yamaguchi Y
    Clin Transplant; 2003; 17 Suppl 10():9-13. PubMed ID: 12823250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of ABO Incompatibility on the Outcomes of Hematopoietic Stem Cell Transplantation: A Single-Center Study From Pakistan.
    Borhany M; Ali MS; Ghias Z; Abid M; Zafar S; Shamsi T
    Cureus; 2023 Sep; 15(9):e45442. PubMed ID: 37859904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carboxyhemoglobin measurements in the diagnosis of ABO hemolytic disease.
    Uetani Y; Nakamura H; Okamoto O; Yamazaki T; Vreman HJ; Stevenson DK
    Acta Paediatr Jpn; 1989 Apr; 31(2):171-6. PubMed ID: 2516696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of ABO incompatibility on patients' outcome after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia - a report from the Acute Leukemia Working Party of the EBMT.
    Canaani J; Savani BN; Labopin M; Huang XJ; Ciceri F; Arcese W; Tischer J; Koc Y; Bruno B; Gülbas Z; Blaise D; Maertens J; Ehninger G; Mohty M; Nagler A
    Haematologica; 2017 Jun; 102(6):1066-1074. PubMed ID: 28255020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sixth hour transcutaneous bilirubin predicting significant hyperbilirubinemia in ABO incompatible neonates.
    Bhat RY; Kumar PC
    World J Pediatr; 2014 May; 10(2):182-5. PubMed ID: 23775679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning.
    Watz E; Remberger M; Ringden O; Lundahl J; Ljungman P; Mattsson J; Wikman A; Uhlin M
    Biol Blood Marrow Transplant; 2014 Feb; 20(2):264-71. PubMed ID: 24274982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning.
    Hefazi M; Litzow M; Hogan W; Gastineau D; Jacob E; Damlaj M; Hashmi S; Al-Kali A; Patnaik MM
    Transfusion; 2016 Feb; 56(2):518-27. PubMed ID: 26446051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of peri-transplant RBC transfusion and ABO incompatibility on acute graft-versus-host disease in pediatric hematopoietic stem cell transplant patients.
    Sever T; Kirkiz S; Kaya Z; Kocak U
    Transfus Apher Sci; 2022 Jun; 61(3):103352. PubMed ID: 35074273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.